Accounts Payable, Current of Cellectar Biosciences, Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary: Cellectar Biosciences, Inc. quarterly Accounts Payable, Current in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
Cellectar Biosciences, Inc. Accounts Payable, Current for the quarter ending 31 Dec 2025 was $1,441,000, a 65% decline year-over-year.
Source SEC data: View on sec.gov

Accounts Payable, Current, Quarterly (USD)

Accounts Payable, Current, YoY Quarterly Change (%)

Cellectar Biosciences, Inc. Quarterly Accounts Payable, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$1,441,000	-$2,664,000	-65%	31 Dec 2025	10-K	04 Mar 2026	2025	FY
Q4 2024	$4,105,000	-$1,515,000	-27%	31 Dec 2024	10-K	04 Mar 2026	2025	FY
Q4 2023	$5,620,000	+$3,062,000	+120%	31 Dec 2023	10-K	13 Mar 2025	2024	FY
Q4 2022	$2,558,000	+$1,143,000	+81%	31 Dec 2022	10-K/A	29 Oct 2024	2023	FY
Q4 2021	$1,415,000	-$14,000	-0.98%	31 Dec 2021	10-K	09 Mar 2023	2022	FY
Q4 2020	$1,429,000	+$151,000	+12%	31 Dec 2020	10-K	21 Mar 2022	2021	FY
Q4 2019	$1,278,000	+$666,000	+109%	31 Dec 2019	10-K	02 Mar 2021	2020	FY
Q4 2018	$612,000	-$321,000	-34%	31 Dec 2018	10-K	09 Mar 2020	2019	FY
Q4 2017	$933,000			31 Dec 2017	10-K	26 Feb 2019	2018	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.